Jk


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
05 2021
Historique:
received: 02 10 2020
accepted: 23 12 2020
pubmed: 5 2 2021
medline: 3 9 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

As of publication, a total of 41 null alleles have been acknowledged by the International Society of Blood Transfusion (ISBT) to cause the rare Jk Two patients with anti-Jk3 were serologically identified by a positive antibody screening and typed as Jk(a-b-). The initial genotyping using an SSP-PCR method for the common 838A/G polymorphism indicated a JK*02/02, or JK*01/02 genotype, respectively. To find the disruptive mutations, Sanger sequencing was performed and results were compared to the reference sequence. The patient's antibodies were characterized with a monocyte monolayer assay (MMA) for their potential clinical significance. Three novel null-mutations of the SLC14A1 gene were found in two patients. Patient 1 was homozygous for a 10bp deletion in exon 4 (c.157_166del on JK*02). Testing of her family members revealed Mendelian inheritance of the deletional allele. The other patient was compound heterozygous for two mutations: one allele carrying a single base deletion in exon 4 (c.267delC on JK*01) and the other a splice site mutation in intron 3 (c.152-1g>a on JK*02). The MMA results suggest high clinical significance of the anti-Jk3 in both patients. The detected mutations led to Jk

Sections du résumé

BACKGROUND
As of publication, a total of 41 null alleles have been acknowledged by the International Society of Blood Transfusion (ISBT) to cause the rare Jk
MATERIALS AND METHODS
Two patients with anti-Jk3 were serologically identified by a positive antibody screening and typed as Jk(a-b-). The initial genotyping using an SSP-PCR method for the common 838A/G polymorphism indicated a JK*02/02, or JK*01/02 genotype, respectively. To find the disruptive mutations, Sanger sequencing was performed and results were compared to the reference sequence. The patient's antibodies were characterized with a monocyte monolayer assay (MMA) for their potential clinical significance.
RESULTS
Three novel null-mutations of the SLC14A1 gene were found in two patients. Patient 1 was homozygous for a 10bp deletion in exon 4 (c.157_166del on JK*02). Testing of her family members revealed Mendelian inheritance of the deletional allele. The other patient was compound heterozygous for two mutations: one allele carrying a single base deletion in exon 4 (c.267delC on JK*01) and the other a splice site mutation in intron 3 (c.152-1g>a on JK*02). The MMA results suggest high clinical significance of the anti-Jk3 in both patients.
DISCUSSION
The detected mutations led to Jk

Identifiants

pubmed: 33539287
pii: 2021.0349-20
doi: 10.2450/2021.0349-20
pmc: PMC8092040
doi:

Substances chimiques

Kidd Blood-Group System 0
Membrane Transport Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-243

Références

Transfusion. 2000 Jan;40(1):69-74
pubmed: 10644814
Transfusion. 2013 Mar;53(3):545-53
pubmed: 22738189
Haematologia (Budap). 1976;10(3-4):403-10
pubmed: 1028674
Transfusion. 1990 Jan;30(1):46-50
pubmed: 2296791
Arch Pathol Lab Med. 1999 Oct;123(10):949-51
pubmed: 10506452
Transfus Med Rev. 2017 Jul;31(3):165-172
pubmed: 28065763
J Clin Lab Anal. 2018 Feb;32(2):
pubmed: 28568311
Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99
pubmed: 15040442
J Biol Chem. 2002 Sep 13;277(37):34101-8
pubmed: 12093813
Vox Sang. 1982;43(6):340-4
pubmed: 7179859
Transfusion. 1965 Jul-Aug;5:315-9
pubmed: 14316530
Vox Sang. 2012 Apr;102(3):234-42
pubmed: 22098427
Nucleic Acids Res. 2018 Jan 4;46(D1):D8-D13
pubmed: 29140470
Blood. 2002 Feb 1;99(3):1079-81
pubmed: 11807016
Transfusion. 1980 Mar-Apr;20(2):189-91
pubmed: 7368267
Nature. 1951 Aug 4;168(4266):207-8
pubmed: 14875052
Nucleic Acids Res. 2000 Jan 1;28(1):352-5
pubmed: 10592272
Blood Transfus. 2010 Jan;8(1):17-20
pubmed: 20104274
Nature. 1953 Mar 7;171(4349):431
pubmed: 13046499
Hum Mol Genet. 1997 Jul;6(7):1017-20
pubmed: 9215669
Transfusion. 2004 Sep;44(9):1273-81
pubmed: 15318848
Transfusion. 1995 Mar;35(3):277
pubmed: 7878726
Br J Haematol. 2002 Feb;116(2):445-53
pubmed: 11841450
Transfusion. 1964 Jul-Aug;4:285-92
pubmed: 14177382
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W597-603
pubmed: 22661580

Auteurs

Wolfgang Allhoff (W)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria.

Lisa Weidner (L)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria.

Nadja Lindlbauer (N)

Department of Transfusion Medicine, Paracelsus Medical University Hospital Salzburg, Salzburg, Austria.

Lydia Grüner (L)

Department of Transfusion Medicine, Paracelsus Medical University Hospital Salzburg, Salzburg, Austria.

Manuel Libisch (M)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria.

Elisabeth Schistal (E)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria.

Christof Jungbauer (C)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH